Business
Abattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons
Abattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n\n\n\nAbattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons\n\n\n\n\n\nAbattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons\nPR Newswire\nVANCOUVER, British Columbia, November 27, 2018\n\n\n\nVANCOUVER, British Columbia, November 27, 2018 /PRNewswire/ --\n\nAbattis Bioceuticals Corp (the \"Company\" or \"Abattis\") (CSE: ATT) (OTC: ATTBF) is pleased to announce that the Company has signed a Distribution Agreement (the \"Distribution Agreement\") with Shefield & Sons Tobacconists Inc. (\"Shefield & Sons\") to sell the Abattis vaporizer line in all Shefield & Sons stores across Canada.\n\nShefield & Sons has been in business since 1976 and is one of Canada's pre-eminent tobacconist franchisors with locations in major cities across Canada. Shefield & Sons offers an extensive tobacco section and in the last 3 years has entered the lucrative cannabis space providing consumers with an array of complimentary products such as vaporizers, pipes and grinders.\n\n\"The Company's Distribution Agreement with Shefield & Sons marks a monumental step forward in consumer exposure to the Company's retail vaporizer line,\" stated Robert Abenante, President and CEO of Abattis.\n\n\"The Company is excited to announce this partnership with Shefield & Sons. By leveraging their brand name, image and vast distribution outlets across Canada, we expect significant growth in our vaporizer sales. In anticipation of our LP license, we are now more focused than ever on securing vaporizer distribution agreements and strategic partnerships with well-known franchises like Shefield & Sons. This Distribution Agreement offers tremendous value to our partners, shareholders and customers,\" added Mr. Abenante.\n\nAbattis' vaporizers provide therapeutic benefits in the delivery of cannabidiol and tetrahydrocannabinol extracts, utilizing a system of rapid absorption for the quick delivery of cannabinoids. With the Distribution Agreement in place, the Company is anticipating increased sales growth of its entire vaporizer line for 2019.\n\nThe current market for Abattis vaporizers is looking very promising. According to data by Wells Fargo and Agora Financial, \"Vapes are proving to be more than just a short-term fad as 'vaping' has picked up steam dramatically in the last ten ...